Christos Reppas1, Eleni Karatza1, Constantinos Goumas2, Constantinos Markopoulos1, Maria Vertzoni3. 1. Faculty of Pharmacy, School of Health Sciences, National & Kapodistrian University of Athens, Panepistimiopolis, 157 71, Zografou, Greece. 2. Red Cross Hospital of Athens, Athens, Greece. 3. Faculty of Pharmacy, School of Health Sciences, National & Kapodistrian University of Athens, Panepistimiopolis, 157 71, Zografou, Greece. vertzoni@pharm.uoa.gr.
Abstract
PURPOSE: Characterize the contents of distal ileum and cecum in healthy adults under conditions simulating the bioavailability/bioequivelance studies of drug products in fasted and fed state. METHODS:Twelve males participated in a two-phase crossover study. Phase I: subjects remained fasted overnight plus 4.5 h in the morning prior to colonoscopy. Phase II: subjects remained fasted overnight, consumed breakfast in the morning, and abstain from food until colonoscopy, 4.5 h after breakfast. Upon sampling, volume, pH and buffer capacity were measured; after ultracentrifugation, supernatant was physicochemically characterized and non-liquid particles diameter was measured. RESULTS: In distal ileum, pH is ~8.1 and size of non-liquid particles is ~200 μm, regardless of dosing conditions; in fed state, liquid fraction was lower whereas osmolality and carbohydrate content were higher. In cecum, the environment was similar with previously characterized environment in the ascending colon; in fasted state, size of non-liquid particles is smaller than in distal ileum (~70 μm). Fluid composition in distal ileum is different from cecum, especially in fasted state. CONCLUSION: Differences in luminal environment between distal ileum and cecum may impact the performance of orally administered products which deliver drug during residence in lower intestine. Dosing conditions affect cecal environment more than in distal ileum.
RCT Entities:
PURPOSE: Characterize the contents of distal ileum and cecum in healthy adults under conditions simulating the bioavailability/bioequivelance studies of drug products in fasted and fed state. METHODS: Twelve males participated in a two-phase crossover study. Phase I: subjects remained fasted overnight plus 4.5 h in the morning prior to colonoscopy. Phase II: subjects remained fasted overnight, consumed breakfast in the morning, and abstain from food until colonoscopy, 4.5 h after breakfast. Upon sampling, volume, pH and buffer capacity were measured; after ultracentrifugation, supernatant was physicochemically characterized and non-liquid particles diameter was measured. RESULTS: In distal ileum, pH is ~8.1 and size of non-liquid particles is ~200 μm, regardless of dosing conditions; in fed state, liquid fraction was lower whereas osmolality and carbohydrate content were higher. In cecum, the environment was similar with previously characterized environment in the ascending colon; in fasted state, size of non-liquid particles is smaller than in distal ileum (~70 μm). Fluid composition in distal ileum is different from cecum, especially in fasted state. CONCLUSION: Differences in luminal environment between distal ileum and cecum may impact the performance of orally administered products which deliver drug during residence in lower intestine. Dosing conditions affect cecal environment more than in distal ileum.
Entities:
Keywords:
fasted state; fed state; human cecum; human ileum; luminal composition
Authors: J Fallingborg; L A Christensen; M Ingeman-Nielsen; B A Jacobsen; K Abildgaard; H H Rasmussen Journal: Aliment Pharmacol Ther Date: 1989-12 Impact factor: 8.171
Authors: Maria Vertzoni; Konstantinos Goumas; Erik Söderlind; Bertil Abrahamsson; Jennifer B Dressman; Androniki Poulou; Christos Reppas Journal: Pharm Res Date: 2010-04-29 Impact factor: 4.200
Authors: Vikas Kumar; Amit K Sinha; Harinder P S Makkar; Gudrun de Boeck; Klaus Becker Journal: Crit Rev Food Sci Nutr Date: 2012 Impact factor: 11.176
Authors: Mahmoud E Soliman; Adeniyi T Adewumi; Oluwole B Akawa; Temitayo I Subair; Felix O Okunlola; Oluwayimika E Akinsuku; Shahzeb Khan Journal: AAPS PharmSciTech Date: 2022-03-15 Impact factor: 3.246
Authors: Mark McAllister; Talia Flanagan; Susan Cole; Andreas Abend; Evangelos Kotzagiorgis; Jobst Limberg; Heather Mead; Victor Mangas-Sanjuan; Paul A Dickinson; Andrea Moir; Xavier Pepin; Diansong Zhou; Christophe Tistaert; Aristides Dokoumetzidis; Om Anand; Maxime Le Merdy; David B Turner; Brendan T Griffin; Adam Darwich; Jennifer Dressman; Claire Mackie Journal: Pharmaceutics Date: 2022-05-07 Impact factor: 6.525
Authors: Yasuhiro Tsume; Sanjaykumar Patel; Nikoletta Fotaki; Christel Bergstrӧm; Gordon L Amidon; James G Brasseur; Deanna M Mudie; Duxin Sun; Marival Bermejo; Ping Gao; Wei Zhu; David C Sperry; Maria Vertzoni; Neil Parrott; Robert Lionberger; Atsushi Kambayashi; Andre Hermans; Xujin Lu; Gregory E Amidon Journal: AAPS J Date: 2018-09-06 Impact factor: 4.009
Authors: Mauricio A García; Felipe Varum; Jozef Al-Gousous; Michael Hofmann; Susanne Page; Peter Langguth Journal: Pharmaceutics Date: 2022-01-26 Impact factor: 6.321
Authors: Gael Nana; Suparna Mitra; Henry Watson; Caroline Young; Henry M Wood; Sarah L Perry; Amanda D Race; Philip Quirke; Giles J Toogood; Paul M Loadman; Mark A Hull Journal: J Nutr Date: 2021-08-07 Impact factor: 4.798